Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04339998 · ClinicalTrials.gov registry record

Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS)

A clinical trial of COVID-19 and SARS-CoV-2, sponsored by University of Minnesota.

Completed
Registry status
129
Enrollment target
2
Study locations

NCT04339998 is a study of COVID-19 and SARS-CoV-2 that has completed, run by University of Minnesota. The registered enrollment target is 129 participants, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04339998, a study of COVID-19 and SARS-CoV-2, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
129 participants
Enrollment target
2
Study locations

Study Summary

Specific Aims: 1. The investigators will prospectively evaluate and analyze changes in the appearance of the lungs and heart through serial acquisition of focused point-of-care ultrasound images in a cohort of patients with or under investigation for COVID-19. 2. The investigators will correlate changes noted in ultrasound with clinical course and diagnostic evaluation to ascertain whether changes on ultrasound could improve care through earlier diagnosis or identification of patients at high risk of disease progression.

Interventions

  • DIAGNOSTIC_TEST Point-of-Care Ultrasonography (POCUS)

Study Locations (2)

Minnesota

  • University of Minnesota Medical Center (UMMC) - Minneapolis
  • M Health Fairview Bethesda Hospital - Saint Paul

Trial Details

FieldValue
Enrollment Target 129 participants
Start Date 2020-04-15
Est. Completion 2020-10-01

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT04339998

The ClinicalTrials.gov registry entry for NCT04339998 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Point-of-Care Ultrasonography (POCUS) is the first listed.

NCT04339998 reports 2 study locations spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT04339998 about?

NCT04339998 is a clinical study titled "Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS)". Specific Aims: 1. The investigators will prospectively evaluate and analyze changes in the appearance of the lungs and heart through serial acquisition of focused point-of-care ultrasound images in a cohort of patients with or under investigation for COVID-19. 2. The investigators will correlate ch...

What is the current status of trial NCT04339998?

This trial is currently completed. The enrollment target is 129 participants. The study started on 2020-04-15. Estimated completion is 2020-10-01.

What conditions does trial NCT04339998 study?

This clinical trial studies the following conditions: COVID-19, SARS-CoV-2, COVID, Coronavirus Infection.

What interventions are being tested in trial NCT04339998?

The interventions under investigation include: Point-of-Care Ultrasonography (POCUS) (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04339998?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04339998 being conducted?

This trial has 2 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.